Moneycontrol PRO

business

No -ve observation in Sun Pharma warning note: PhillipCap

In an interview to CNBC-TV18, Surya Narayan Patra of PhillipCapital shared his readings and outlook on Sun Pharmaceutical Industries and also spoke about the warning letter which the company has received from USFDA.

first published: Dec 21, 2015 11:34 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347